Ascendis Pharma (ASND) revenue

Revenue · fiscal 2025
€720.13M

Ascendis Pharma (ASND) reported revenue of €720.13M in fiscal 2025 (the year ended December 31, 2025). That is 98.0% higher than the €363.64M of fiscal 2024. Figures as of 18 Nov 2026, 07:29 UTC, from Yahoo Finance.

Key facts

Revenue, fiscal 2025
€720.13M
Change on fiscal 2024
+98.0%
Highest on record
€720.13Mfiscal 2025
Lowest on record
€51.17Mfiscal 2022
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Amounts are in EUR. Figures, not advice.

Ascendis Pharma revenue, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was €720.13M in fiscal 2025 and the lowest €51.17M in fiscal 2022.

History · 4 fiscal years

Revenue by fiscal year

Ascendis Pharma revenue, year by year

Ascendis Pharma (ASND) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025€720.13M 98.0% up
2024€363.64M 36.3% up
2023€266.72M 421.2% up
2022€51.17M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of Ascendis Pharma and comparable companies
CompanyRevenueFiscal year
Revvity RVTY$2.86B2025
Exelixis EXEL$2.32B2025
Charles River Laboratories International CRL$4.02B2025
Neurocrine Biosciences NBIX$2.86B2025
Ascendis Pharma ASND€720.13M2025
ICON ICLR$8.25B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on ASND

Ascendis Pharma, figure by figure

Ascendis Pharma (ASND) overview: price, valuation and scorecardAll health care companies by market value

Ascendis Pharma revenue: questions and answers

What is Ascendis Pharma's revenue?

Ascendis Pharma (ASND) reported revenue of €720.13M in fiscal 2025 (the year ended December 31, 2025). That is 98.0% higher than the €363.64M of fiscal 2024.

What are the highest and lowest revenue figures on record for Ascendis Pharma?

Across the 4 fiscal years on record (2022–2025), the highest was €720.13M in fiscal 2025 and the lowest €51.17M in fiscal 2022.

How is Ascendis Pharma's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Ascendis Pharma (ASND) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/ASND/revenue

Underlying data: Yahoo Finance.